Target Price | CHF167.04 |
Price | CHF145.25 |
Potential | 15.00% |
Number of Estimates | 27 |
27 Analysts have issued a price target Richemont 2026 . The average Richemont target price is CHF167.04. This is 15.00% higher than the current stock price. The highest price target is CHF210.76 45.10% , the lowest is CHF139.07 4.25% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Richemont to buy, 14 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2026 of 15.00% . Most analysts recommend the Richemont stock at Purchase. |
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 19.80 | 20.05 |
0.10% | 1.24% | |
EBITDA Margin | 30.52% | 27.83% |
5.56% | 8.83% | |
Net Margin | 11.64% | 9.80% |
7,788.05% | 15.84% |
27 Analysts have issued a sales forecast Richemont 2025 . The average Richemont sales estimate is CHF20.0b . This is 2.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.2b 8.16% , the lowest is CHF19.3b 1.41% .
This results in the following potential growth metrics:
2024 | CHF19.8b | 0.10% |
---|---|---|
2025 | CHF20.0b | 1.24% |
2026 | CHF21.2b | 5.50% |
2027 | CHF22.6b | 6.76% |
2028 | CHF23.7b | 5.05% |
2029 | CHF25.2b | 6.35% |
24 Analysts have issued an Richemont EBITDA forecast 2025. The average Richemont EBITDA estimate is CHF5.6b . This is 1.28% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF6.0b 5.35% , the lowest is CHF4.6b 18.54% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF6.0b | 5.65% |
---|---|---|
2025 | CHF5.6b | 7.69% |
2026 | CHF6.1b | 9.30% |
2027 | CHF6.8b | 10.70% |
2028 | CHF7.3b | 7.56% |
2024 | 30.52% | 5.56% |
---|---|---|
2025 | 27.83% | 8.83% |
2026 | 28.84% | 3.63% |
2027 | 29.90% | 3.68% |
2028 | 30.62% | 2.41% |
11 Richemont Analysts have issued a net profit forecast 2025. The average Richemont net profit estimate is CHF2.0b . This is 56.79% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF2.2b 77.47% , the lowest is CHF911m 27.26% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF2.3b | 7,780.00% |
---|---|---|
2025 | CHF2.0b | 14.84% |
2026 | CHF3.7b | 89.17% |
2027 | CHF4.2b | 13.30% |
2028 | CHF4.7b | 10.81% |
2024 | 11.64% | 7,788.05% |
---|---|---|
2025 | 9.80% | 15.84% |
2026 | 17.56% | 79.18% |
2027 | 18.64% | 6.15% |
2028 | 19.66% | 5.47% |
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 3.94 | 3.36 |
7,780.00% | 14.72% | |
P/E | 43.29 | |
EV/Sales | 4.16 |
11 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF3.36 . This is 57.01% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF3.80 77.57% , the lowest is CHF1.56 27.10% .
This results in the following potential growth metrics and future valuations:
2024 | CHF3.94 | 7,780.00% |
---|---|---|
2025 | CHF3.36 | 14.72% |
2026 | CHF6.35 | 88.99% |
2027 | CHF7.19 | 13.23% |
2028 | CHF7.97 | 10.85% |
Current | 67.90 | 46.46% |
---|---|---|
2025 | 43.29 | 36.24% |
2026 | 22.88 | 47.15% |
2027 | 20.20 | 11.71% |
2028 | 18.23 | 9.75% |
Based on analysts' sales estimates for 2025, the Richemont stock is valued at an EV/Sales of 4.16 and an P/S ratio of 4.24 .
This results in the following potential growth metrics and future valuations:
Current | 4.26 | 1,604.00% |
---|---|---|
2025 | 4.16 | 2.35% |
2026 | 3.94 | 5.21% |
2027 | 3.69 | 6.33% |
2028 | 3.52 | 4.81% |
2029 | 3.31 | 5.97% |
Current | 4.34 | 1,208.53% |
---|---|---|
2025 | 4.24 | 2.27% |
2026 | 4.02 | 5.21% |
2027 | 3.77 | 6.33% |
2028 | 3.58 | 4.81% |
2029 | 3.37 | 5.97% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Apr 07 2025 |
HSBC |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED |
Neutral
➜
Neutral
|
Unchanged | Mar 19 2025 |
BANCO SANTANDER |
Outperform
➜
Outperform
|
Unchanged | Mar 19 2025 |
TD COWEN |
Hold
➜
Buy
|
Upgrade | Mar 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Apr 07 2025 |
Unchanged
HSBC:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED:
Neutral
➜
Neutral
|
Mar 19 2025 |
Unchanged
BANCO SANTANDER:
Outperform
➜
Outperform
|
Mar 19 2025 |
Upgrade
TD COWEN:
Hold
➜
Buy
|
Mar 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.